Silverarc Capital Management’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-54,822
| Closed | -$1.67M | – | 85 |
|
|
2023
Q4 | $1.67M | Buy |
54,822
+1,804
| +3% | +$55K | 0.5% | 51 |
|
|
2023
Q3 | $1.68M | Buy |
53,018
+2,160
| +4% | +$68.3K | 0.51% | 42 |
|
|
2023
Q2 | $2.07M | Buy |
50,858
+13,000
| +34% | +$530K | 0.64% | 41 |
|
|
2023
Q1 | $1.41M | Buy |
37,858
+5,088
| +16% | +$190K | 0.58% | 47 |
|
|
2022
Q4 | $1.14M | Buy |
32,770
+759
| +2% | +$26.5K | 0.33% | 59 |
|
|
2022
Q3 | $1.79M | Buy |
+32,011
| New | +$1.79M | 0.61% | 41 |
|
|
2021
Q4 | – | Sell |
-4,950
| Closed | -$664K | – | 82 |
|
|
2021
Q3 | $664K | Buy |
+4,950
| New | +$664K | 0.38% | 59 |
|